查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2042711

全球環烯烴聚合物市場：按類型、應用和最終用戶分類－市場規模、產業動態、機會分析和預測（2026-2035 年）

Global Cyclic Olefin Polymer Market: By Type, Application, End User - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035
出版日期: | 出版商: Astute Analytica | 英文 260 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球環烯烴聚合物（COP）市場正經歷穩定且顯著的成長，反映出其在高性能材料應用領域日益重要的角色。預計2025年市場規模約13.5824億美元，2035年將達到約24.7825億美元。這一趨勢意味著2026年至2035年預測期間的複合年成長率約為6.20%。這一成長趨勢凸顯了各行業對高精度、高可靠性和先進材料性能的需求不斷成長。

推動這一成長的主要因素是醫療和電子等高性能領域需求的不斷成長。在醫療產業，由於COP即使在敏感環境下也能保持純度和穩定性，因此被廣泛應用於藥品包裝、醫療設備和診斷系統。同時，在電子產業，COP被用於對尺寸精度和光學性能要求極高的應用，例如顯示技術和精密元件。這些行業需求的融合顯著擴大了該材料的市場佔有率。

顯著的市場趨勢

2025年的競爭格局將呈現極度寡占的特徵，少數幾家高度專業化的公司將主導環烯烴聚合物市場。這種權力集中主要是由於強大的智慧財產權組合保護了專有工藝和配方，以及顯著的技術准入障礙。

該市場的主要領導者包括ZEON Corporation（以其ZEONEX®和ZEONOR®產品線而聞名）以及TOPAS Advanced Polymers and Polyplastics（生產TOPAS®環烯烴共聚物）。其他主要公司包括APEL™的製造商三井化學株式會社和ARTON™的製造商JSR Corporation。

這些領導企業的關鍵特徵在於其對專有茂金屬觸媒技術的精湛掌握，這對於實現高產率和高純度聚合至關重要。這些催化劑能夠精確控制分子結構，使製造商能夠生產出品質穩定、性能優異且雜質含量極低的聚合物。

關鍵成長要素

法律規範正逐漸成為環烯烴聚合物（COP）市場成長的關鍵促進因素。在全球醫藥和醫療保健產業，監管機構不斷加強材料安全標準，特別關注藥物包裝和給藥系統中的萃取劑和洗脫劑（E&L）。這些物質可能從包裝材料遷移到藥物中，對藥物的穩定性、療效和病人安全構成潛在風險。因此，製造商面臨越來越大的壓力，需要在滿足嚴格合規要求的同時，採用能夠最大限度降低這些風險的材料。在這種不斷變化的監管環境下，由於其固有的純淨化學成分，環烯烴聚合物正受到廣泛關注。

新機會的趨勢

市場正日益將目光轉向永續的生物基材料，這為未來的成長創造了巨大的新機會。在日益成長的環境問題和監管壓力下，製造商正積極探索傳統石油基聚合物的替代品。源自可再生資源的生物基材料有望在保持高性能的同時，減少碳排放，滿足高要求應用的需求。這種轉型在醫療保健、包裝和電子等產業尤其重要，因為在這些產業中，永續發展目標與產品創新和長期策略規劃的連結日益緊密。

最佳化障礙

儘管需求強勁且不斷成長，但到2025年，環烯烴聚合物市場仍面臨嚴重的供應鏈瓶頸，阻礙了其高效規模化生產。其中一個主要的結構性挑戰在於生產高度集中在日本和德國等國家。這種集中促使對長途全球分銷網路的依賴，使得供應鏈極易受到干擾。由於這些材料必須跨洲運輸，因此市場高度依賴穩定的海運航線和高度協調的物流系統來確保及時交貨。

目錄

第1章摘要整理：全球環烯烴聚合物市場

第2章：調查方法與研究框架

  • 研究目標
  • 產品概述
  • 市場區隔
  • 定性研究
    • 一手和二手資訊
  • 量化研究
    • 一手和二手資訊
  • 主要調查受訪者組成：按地區分類
  • 本研究的前提
  • 市場規模估算
  • 數據三角測量

第3章：全球環烯烴聚合物市場概述

  • 產業價值鏈分析
  • 產業展望
    • 全球特種聚合物和醫藥包裝產業概覽
    • 監理狀態（FDA 21 CFR、USP VI 類、ISO 10993、EP/USP 藥典）
  • PESTLE分析
  • 波特五力分析
  • 市場成長及前景
    • 2020-2035年市場收入估算與預測
    • 價格趨勢分析：按類型

第4章：全球環烯烴聚合物市場分析

  • 競爭對手儀表板
    • 市場集中度
    • 企業市場占有率分析，2025 年
    • 競爭對手分析與基準測試

第5章：全球環烯烴聚合物市場分析

  • 市場動態和趨勢
    • 成長要素
    • 抑制因子
    • 機會
    • 主要趨勢
  • 市場規模及預測，2020-2035年
    • 按類型
      • 關鍵見解
        • 環烯烴聚合物（COP）
          • 低分子量COP
          • 高分子量COP
        • 環烯烴共聚物（COC）
          • 具有高玻璃化轉變溫度（Tg）的COC
          • 玻璃化轉變溫度（Tg）較低的COC
    • 用途別
      • 關鍵見解
        • 醫藥應用
          • 預填充式注射器
          • 管瓶和安瓿
          • 診斷容器
          • 滴液容器
          • 微流體裝置（晶片實驗室）
          • 吸入器和藥物輸送系統
        • 光學應用
          • 相機鏡頭
          • 光波導
          • 光學薄膜
          • LED透鏡
        • 電子應用
          • 半導體封裝
          • 晶圓載體
          • 顯示組件（導光板、背光模組）
          • 感測器和外殼
        • 包裝（非藥品）
          • 食品包裝（高透明薄膜）
          • 化妝品包裝
        • 其他
          • 3D列印材料
          • 研究設備和實驗室耗材
          • 分析設備
    • 最終用戶
      • 關鍵見解
        • 醫療保健和生命科學
          • 製藥公司
          • 生技公司
          • 醫療設備製造商
        • 電子和半導體行業
        • 食品飲料包裝業
        • 化妝品產業
        • 學術和研究機構
        • 契約製造組織（CMO）和合約開發與生產組織（CDMO）
    • 按地區
      • 關鍵見解
        • 北美洲
          • 美國
          • 加拿大
          • 墨西哥
        • 歐洲
          • 西歐
            • 英國
            • 德國
            • 法國
            • 義大利
            • 西班牙
            • 其他西歐國家
          • 東歐
            • 波蘭
            • 俄羅斯
            • 其他東歐國家
        • 亞太地區
          • 中國
          • 印度
          • 日本
          • 韓國
          • 澳洲和紐西蘭
          • ASEAN
            • 柬埔寨
            • 印尼
            • 馬來西亞
            • 菲律賓
            • 新加坡
            • 泰國
            • 越南
            • 其他東南亞國協
          • 其他亞太國家
        • 中東和非洲
          • UAE
          • 沙烏地阿拉伯
          • 南非
          • 其他中東和非洲國家
        • 南美洲
          • 阿根廷
          • 巴西
          • 其他南美國家

第6章：北美市場分析

第7章：歐洲市場分析

第8章：亞太市場分析

第9章：中東和非洲市場分析

第10章：南美市場分析

第11章：公司簡介

  • Biosynth
  • Borealis AG
  • China Petrochemical Development Corporation
  • Daicel Corporation
  • Mitsui Chemicals, Inc.
  • Polyplastics Co., Ltd.
  • Polysciences, Inc.
  • Saudi Basic Industries Corporation（SABIC）
  • SK Chemicals
  • Sumitomo Bakelite Co., Ltd.
  • TOPAS Advanced Polymers GmbH
  • Zeon Corporation
  • Other Prominent Players

第12章附錄

簡介目錄
Product Code: AA05261782

The global cyclic olefin polymer (COP) market is experiencing steady and meaningful growth, reflecting its expanding role in high-performance material applications. In 2025, the market is valued at approximately USD 1,358.24 million, and it is projected to reach around USD 2,478.25 million by 2035. This progression represents a compound annual growth rate (CAGR) of about 6.20% during the forecast period from 2026 to 2035. The upward trajectory highlights increasing adoption across industries that demand precision, reliability, and advanced material properties.

A major driver behind this growth is the rising demand from high-performance sectors such as healthcare and electronics. In the healthcare industry, COP is widely used in pharmaceutical packaging, medical devices, and diagnostic systems due to its ability to maintain purity and stability in sensitive environments. At the same time, the electronics sector leverages COP for applications requiring dimensional accuracy and optical performance, including display technologies and precision components. The convergence of these industries' needs is significantly expanding the material's market footprint.

Noteworthy Market Developments

The competitive landscape in 2025 is defined by a distinctly oligopolistic structure, where a small number of highly specialized players dominate the cyclic olefin polymer market. This concentration of power is largely the result of significant technological barriers to entry, as well as deeply entrenched intellectual property portfolios that protect proprietary processes and formulations.

At the forefront of this market are key industry leaders such as Zeon Corporation, known for its ZEONEX(R) and ZEONOR(R) product lines, along with TOPAS Advanced Polymers and Polyplastics, which produce TOPAS(R) cyclic olefin copolymers. Other major players include Mitsui Chemicals, the manufacturer of APEL(TM), and JSR Corporation, which produces ARTON(TM).

A defining characteristic of these leading firms is their control over proprietary metallocene catalyst technologies, which are essential for achieving high-yield and high-purity polymerization. These catalysts enable precise control over molecular structure, allowing manufacturers to produce polymers with consistent quality, tailored performance characteristics, and minimal impurities.

Core Growth Drivers

The regulatory framework is emerging as a key catalyst driving growth in the cyclic olefin polymer (COP) market. Across global pharmaceutical and healthcare industries, regulatory authorities are continuously tightening standards related to material safety, particularly concerning Extractables and Leachables (E&L) in drug packaging and delivery systems. These substances, which can migrate from packaging materials into pharmaceutical products, pose potential risks to drug stability, efficacy, and patient safety. As a result, manufacturers are under increasing pressure to adopt materials that minimize such risks while meeting strict compliance requirements. In this evolving regulatory landscape, COP has gained significant traction due to its inherently pure chemical composition.

Emerging Opportunity Trends

The market is increasingly shifting its focus toward sustainable, bio-based materials, creating a significant emerging opportunity for future growth. As environmental concerns intensify and regulatory pressures become more stringent, manufacturers are actively exploring alternatives to traditional petroleum-based polymers. Bio-based materials, derived from renewable feedstocks, offer the potential to reduce carbon footprints while maintaining the high-performance characteristics required for demanding applications. This transition is particularly relevant in industries such as healthcare, packaging, and electronics, where sustainability goals are becoming closely aligned with product innovation and long-term strategic planning.

Barriers to Optimization

Despite strong and growing demand, the cyclic olefin polymer market is facing significant supply chain bottlenecks in 2025 that constrain its ability to scale efficiently. A major structural challenge lies in the geographic concentration of production, which is heavily centered in countries such as Japan and Germany. This concentration creates a dependency on long-distance global distribution networks, making the supply chain particularly vulnerable to disruptions. Since these materials must be transported across continents, the market relies extensively on stable maritime shipping routes and highly coordinated logistics systems to ensure timely delivery.

Detailed Market Segmentation

By application, the pharmaceutical and medical segment accounted for the largest share of the market in 2025, contributing approximately 60.84% of total revenue. This strong position reflects the critical role that high-performance materials play in ensuring the safety, stability, and effectiveness of medical products. The segment covers a wide range of essential drug delivery and storage formats, including pre-filled syringes, vials, intravenous (IV) bottles, and wearable pump cartridges. Each of these applications requires materials that can maintain strict quality standards while supporting the safe handling of sensitive pharmaceutical formulations.

By end-user, the healthcare and life sciences segment accounted for the largest share of the market in 2025, representing approximately 65.12% of total revenue. This dominant position is driven by the extensive and growing use of advanced materials across a wide spectrum of medical and scientific applications. Within this ecosystem, demand extends far beyond traditional pharmaceutical drug delivery systems to include a broad range of highly specialized life science processes that require precision, reliability, and material purity.

By type, the cyclic olefin copolymer segment accounts for the largest share of the cyclic olefin polymer market, holding approximately 69% of total revenue. This dominance is largely attributed to the material's unique combination of performance characteristics and economic efficiency, which makes it particularly well suited for high-volume, industrial-scale applications. Cyclic olefin copolymer offers a highly favorable cost-to-performance ratio, allowing manufacturers to achieve the necessary material properties for demanding uses without incurring high costs. As a result, it has become the preferred choice in applications such as pharmaceutical blister packaging and diagnostic point-of-care test strips, where both precision and scalability are critical.

Segment Breakdown

By Type

  • Cyclic Olefin Polymer (COP)
  • Low Molecular Weight COP
  • High Molecular Weight COP
  • Cyclic Olefin Copolymer (COC)
  • COC with High Glass Transition Temperature (Tg)
  • COC with Low Glass Transition Temperature (Tg)

By Application

  • Pharmaceutical & Medical Applications
  • Pre-filled Syringes
  • Vials & Ampoules
  • Diagnostic Containers
  • IV Containers
  • Microfluidic Devices (Lab-on-a-chip)
  • Inhalers and Drug Delivery Systems
  • Optical Applications
  • Camera Lenses
  • Light Guides
  • Optical Films
  • LED Lenses
  • Electronics Applications
  • Semiconductor Packaging
  • Wafer Carriers
  • Display Components (Light Guides, Backlight Units)
  • Sensors and Housings
  • Packaging (non-pharmaceutical)
  • Food Packaging (high-clarity films)
  • Cosmetic Packaging
  • Others
  • 3D Printing Materials
  • Research Tools and Lab Consumables
  • Analytical Devices

By End User

  • Healthcare & Life Sciences
  • Pharmaceutical Companies
  • Biotech Firms
  • Medical Device Manufacturers
  • Electronics & Semiconductor Industry
  • Food & Beverage Packaging Industry
  • Cosmetic Industry
  • Academic & Research Institutions
  • Contract Manufacturing Organizations (CMOs) & CDMOs

By Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Geography Breakdown

  • North America holds the dominant position in the cyclic olefin polymer market, accounting for approximately 51.68% of global revenue in 2025. This leadership is largely driven by strong demand from the biopharmaceutical sector, which continues to expand rapidly across the region. The increasing production of advanced therapies such as monoclonal antibodies, mRNA-based treatments, and GLP-1 drugs has significantly accelerated the shift away from traditional glass packaging toward high-performance polymer alternatives.
  • A critical factor supporting this transition is the high average revenue per unit associated with these advanced therapeutics. Because these drugs are often extremely valuable, manufacturers are more willing to absorb the higher cost of cyclic olefin polymers, which can exceed $20 per kilogram. This premium is justified by the material's ability to reduce the risk of batch failures caused by issues commonly associated with glass, such as breakage, delamination, or chemical interaction. Avoiding such losses is essential in high-value drug production, where even a single compromised batch can result in significant financial and operational setbacks.

Leading Market Participants

  • Biosynth
  • Borealis AG
  • China Petrochemical Development Corporation
  • Daicel Corporation
  • Mitsui Chemicals, Inc.
  • Polysciences, Inc.
  • Polyplastics Co., Ltd.
  • Saudi Basic Industries Corporation (SABIC)
  • SK Chemicals
  • Sumitomo Bakelite Co., Ltd.
  • TOPAS Advanced Polymers GmbH
  • Zeon Corporation

Table of Content

Chapter 1. Executive Summary: Global Cyclic Olefin Polymer Market

Chapter 2. Research Methodology & Research Framework

  • 2.1. Research Objective
  • 2.2. Product Overview
  • 2.3. Market Segmentation
  • 2.4. Qualitative Research
    • 2.4.1. Primary & Secondary Sources
  • 2.5. Quantitative Research
    • 2.5.1. Primary & Secondary Sources
  • 2.6. Breakdown of Primary Research Respondents, By Region
  • 2.7. Assumption for Study
  • 2.8. Market Size Estimation
  • 2.9. Data Triangulation

Chapter 3. Global Cyclic Olefin Polymer Market Overview

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. Raw Material & Monomer Suppliers (DCPD, Norbornene, Ethylene)
    • 3.1.2. Catalyst & Specialty Chemical Providers (Metallocene Catalysts)
    • 3.1.3. COP/COC Polymer Manufacturers (Tier 1 Producers)
    • 3.1.4. Compounders, Distributors & Specialty Resin Suppliers
    • 3.1.5. Converters & Processors (Injection Molders, Film Extruders, Thermoformers)
    • 3.1.6. Pharmaceutical Packaging, Optical, Electronics & Diagnostic OEMs
    • 3.1.7. End Users (Healthcare & Life Sciences, Electronics, Food & Beverage Packaging)
  • 3.2. Industry Outlook
    • 3.2.1. Overview of the Global Specialty Polymer & Pharmaceutical Packaging Industry
    • 3.2.2. Regulatory Landscape (FDA 21 CFR, USP Class VI, ISO 10993, EP/USP Pharmacopoeia)
  • 3.3. PESTLE Analysis
  • 3.4. Porter's Five Forces Analysis
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of Substitutes
    • 3.4.4. Threat of New Entrants
    • 3.4.5. Degree of Competition
  • 3.5. Market Growth and Outlook
    • 3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
    • 3.5.2. Price Trend Analysis, By Type

Chapter 4. Global Cyclic Olefin Polymer Market Analysis

  • 4.1. Competition Dashboard
    • 4.1.1. Market Concentration Rate
    • 4.1.2. Company Market Share Analysis (Value %), 2025
    • 4.1.3. Competitor Mapping & Benchmarking

Chapter 5. Global Cyclic Olefin Polymer Market Analysis

  • 5.1. Market Dynamics and Trends
    • 5.1.1. Growth Drivers
    • 5.1.2. Restraints
    • 5.1.3. Opportunity
    • 5.1.4. Key Trends
  • 5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 5.2.1. By Type
      • 5.2.1.1. Key Insights
        • 5.2.1.1.1. Cyclic Olefin Polymer (COP)
          • 5.2.1.1.1.1. Low Molecular Weight COP
          • 5.2.1.1.1.2. High Molecular Weight COP
        • 5.2.1.1.2. Cyclic Olefin Copolymer (COC)
          • 5.2.1.1.2.1. COC with High Glass Transition Temperature (Tg)
          • 5.2.1.1.2.2. COC with Low Glass Transition Temperature (Tg)
    • 5.2.2. By Application
      • 5.2.2.1. Key Insights
        • 5.2.2.1.1. Pharmaceutical & Medical Applications
          • 5.2.2.1.1.1. Pre-filled Syringes
          • 5.2.2.1.1.2. Vials & Ampoules
          • 5.2.2.1.1.3. Diagnostic Containers
          • 5.2.2.1.1.4. IV Containers
          • 5.2.2.1.1.5. Microfluidic Devices (Lab-on-a-chip)
          • 5.2.2.1.1.6. Inhalers and Drug Delivery Systems
        • 5.2.2.1.2. Optical Applications
          • 5.2.2.1.2.1. Camera Lenses
          • 5.2.2.1.2.2. Light Guides
          • 5.2.2.1.2.3. Optical Films
          • 5.2.2.1.2.4. LED Lenses
        • 5.2.2.1.3. Electronics Applications
          • 5.2.2.1.3.1. Semiconductor Packaging
          • 5.2.2.1.3.2. Wafer Carriers
          • 5.2.2.1.3.3. Display Components (Light Guides, Backlight Units)
          • 5.2.2.1.3.4. Sensors and Housings
        • 5.2.2.1.4. Packaging (non-pharmaceutical)
          • 5.2.2.1.4.1. Food Packaging (high-clarity films)
          • 5.2.2.1.4.2. Cosmetic Packaging
        • 5.2.2.1.5. Others
          • 5.2.2.1.5.1. 3D Printing Materials
          • 5.2.2.1.5.2. Research Tools and Lab Consumables
          • 5.2.2.1.5.3. Analytical Devices
    • 5.2.3. By End User
      • 5.2.3.1. Key Insights
        • 5.2.3.1.1. Healthcare & Life Sciences
          • 5.2.3.1.1.1. Pharmaceutical Companies
          • 5.2.3.1.1.2. Biotech Firms
          • 5.2.3.1.1.3. Medical Device Manufacturers
        • 5.2.3.1.2. Electronics & Semiconductor Industry
        • 5.2.3.1.3. Food & Beverage Packaging Industry
        • 5.2.3.1.4. Cosmetic Industry
        • 5.2.3.1.5. Academic & Research Institutions
        • 5.2.3.1.6. Contract Manufacturing Organizations (CMOs) & CDMOs
    • 5.2.4. By Region
      • 5.2.4.1. Key Insights
        • 5.2.4.1.1. North America
          • 5.2.4.1.1.1. The U.S.
          • 5.2.4.1.1.2. Canada
          • 5.2.4.1.1.3. Mexico
        • 5.2.4.1.2. Europe
          • 5.2.4.1.2.1. Western Europe
            • 5.2.4.1.2.1.1. The UK
            • 5.2.4.1.2.1.2. Germany
            • 5.2.4.1.2.1.3. France
            • 5.2.4.1.2.1.4. Italy
            • 5.2.4.1.2.1.5. Spain
            • 5.2.4.1.2.1.6. Rest of Western Europe
          • 5.2.4.1.2.2. Eastern Europe
            • 5.2.4.1.2.2.1. Poland
            • 5.2.4.1.2.2.2. Russia
            • 5.2.4.1.2.2.3. Rest of Eastern Europe
        • 5.2.4.1.3. Asia Pacific
          • 5.2.4.1.3.1. China
          • 5.2.4.1.3.2. India
          • 5.2.4.1.3.3. Japan
          • 5.2.4.1.3.4. South Korea
          • 5.2.4.1.3.5. Australia & New Zealand
          • 5.2.4.1.3.6. ASEAN
            • 5.2.4.1.3.6.1. Cambodia
            • 5.2.4.1.3.6.2. Indonesia
            • 5.2.4.1.3.6.3. Malaysia
            • 5.2.4.1.3.6.4. Philippines
            • 5.2.4.1.3.6.5. Singapore
            • 5.2.4.1.3.6.6. Thailand
            • 5.2.4.1.3.6.7. Vietnam
            • 5.2.4.1.3.6.8. Rest of ASEAN
          • 5.2.4.1.3.7. Rest of Asia Pacific
        • 5.2.4.1.4. Middle East & Africa
          • 5.2.4.1.4.1. UAE
          • 5.2.4.1.4.2. Saudi Arabia
          • 5.2.4.1.4.3. South Africa
          • 5.2.4.1.4.4. Rest of MEA
        • 5.2.4.1.5. South America
          • 5.2.4.1.5.1. Argentina
          • 5.2.4.1.5.2. Brazil
          • 5.2.4.1.5.3. Rest of South America

Chapter 6. North America Market Analysis

  • 6.1. Market Dynamics and Trends
    • 6.1.1. Growth Drivers
    • 6.1.2. Restraints
    • 6.1.3. Opportunity
    • 6.1.4. Key Trends
  • 6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 6.2.1. Key Insights
      • 6.2.1.1. By Type
      • 6.2.1.2. By Application
      • 6.2.1.3. By End User
      • 6.2.1.4. By Country

Chapter 7. Europe Market Analysis

  • 7.1. Market Dynamics and Trends
    • 7.1.1. Growth Drivers
    • 7.1.2. Restraints
    • 7.1.3. Opportunity
    • 7.1.4. Key Trends
  • 7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 7.2.1. Key Insights
      • 7.2.1.1. By Type
      • 7.2.1.2. By Application
      • 7.2.1.3. By End User
      • 7.2.1.4. By Country

Chapter 8. Asia Pacific Market Analysis

  • 8.1. Market Dynamics and Trends
    • 8.1.1. Growth Drivers
    • 8.1.2. Restraints
    • 8.1.3. Opportunity
    • 8.1.4. Key Trends
  • 8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 8.2.1. Key Insights
      • 8.2.1.1. By Type
      • 8.2.1.2. By Application
      • 8.2.1.3. By End User
      • 8.2.1.4. By Country

Chapter 9. Middle East & Africa Market Analysis

  • 9.1. Market Dynamics and Trends
    • 9.1.1. Growth Drivers
    • 9.1.2. Restraints
    • 9.1.3. Opportunity
    • 9.1.4. Key Trends
  • 9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 9.2.1. Key Insights
      • 9.2.1.1. By Type
      • 9.2.1.2. By Application
      • 9.2.1.3. By End User
      • 9.2.1.4. By Country

Chapter 10. South America Market Analysis

  • 10.1. Market Dynamics and Trends
    • 10.1.1. Growth Drivers
    • 10.1.2. Restraints
    • 10.1.3. Opportunity
    • 10.1.4. Key Trends
  • 10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 10.2.1. Key Insights
      • 10.2.1.1. By Type
      • 10.2.1.2. By Application
      • 10.2.1.3. By End User
      • 10.2.1.4. By Country

Chapter 11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 11.1. Biosynth
  • 11.2. Borealis AG
  • 11.3. China Petrochemical Development Corporation
  • 11.4. Daicel Corporation
  • 11.5. Mitsui Chemicals, Inc.
  • 11.6. Polyplastics Co., Ltd.
  • 11.7. Polysciences, Inc.
  • 11.8. Saudi Basic Industries Corporation (SABIC)
  • 11.9. SK Chemicals
  • 11.10. Sumitomo Bakelite Co., Ltd.
  • 11.11. TOPAS Advanced Polymers GmbH
  • 11.12. Zeon Corporation
  • 11.13. Other Prominent Players

Chapter 12. Annexure

  • 12.1. List of Secondary Sources
  • 12.2. Key Country Markets- Macro Economic Outlook/Indicators